Glendon E. French III - 20 Jan 2022 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Issuer symbol
LUNG
Transactions as of
20 Jan 2022
Net transactions value
-$627,696
Form type
4
Filing time
24 Jan 2022, 16:41:40 UTC
Previous filing
17 Dec 2021
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Sale $324,750 -12,500 -1.1% $25.98 1,101,449 20 Jan 2022 Direct F1, F2
transaction LUNG Common Stock Sale $293,377 -12,113 -1.1% $24.22 1,089,336 21 Jan 2022 Direct F1, F3
transaction LUNG Common Stock Sale $4,623 -187 -0.02% $24.72 1,089,149 21 Jan 2022 Direct F1
transaction LUNG Common Stock Sale $4,946 -200 -0.02% $24.73 1,088,949 21 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.33 to $26.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.